Drug Shortage Report for TEVA-ZOLMITRIPTAN OD

Last updated on 2022-12-01 History
Report ID 161012
Drug Identification Number 02342545
Brand name TEVA-ZOLMITRIPTAN OD
Common or Proper name ZOLMITRIPTAN 2.5MG OD TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ZOLMITRIPTAN
Strength(s) 2.5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size P PACK 6
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-03-18
Estimated end date 2024-06-30
Actual end date
Shortage status Actual shortage
Updated date 2022-12-01
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2022-12-01 French Compare
v15 2022-12-01 English Compare
v14 2022-11-14 French Compare
v13 2022-11-14 English Compare
v12 2022-10-28 French Compare
v11 2022-10-28 English Compare
v10 2022-09-07 French Compare
v9 2022-09-07 English Compare
v8 2022-08-18 French Compare
v7 2022-08-18 English Compare
v6 2022-06-30 French Compare
v5 2022-06-30 English Compare
v4 2022-06-03 French Compare
v3 2022-06-03 English Compare
v2 2022-05-19 French Compare
v1 2022-05-19 English Compare

Showing 1 to 16 of 16